Serodus ASA


Cardiovascular diseases are one of the largest health issues in the world. Serodus is committed to contribute to the treatment of these disorders:


  • SER100 Therapy resistant islolated systolic hypertension
  • SER150 Diabetic nephropathy
  • SER130 Acute Myocardial Infarction
  • SER140 Type 2 Diabetes

Why Serodus

Cardiovascular and metabolic diseases have large patient populations with unmet needs.

Why Serodus